Casodex (a nonsteroidal antiandrogen) reduces cancellous, endosteal, and periosteal bone formation in estrogen-replete female rats

Calcified Tissue International

Volumn 58, Issue 4, 1996, Pages 268-272

  Lea, C ^a   Kendall, N ^a   Flanagan, A M ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Anti androgen; Bone formation; Bone resorption; Osteoblast; Osteoclast

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; BICALUTAMIDE; ESTRADIOL; ESTROGEN; ESTRONE; PRASTERONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; CANCELLOUS BONE; CONTROLLED STUDY; DIAPHYSIS; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; METAPHYSIS; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT;

ANDROGEN ANTAGONISTS; ANDROGENS; ANILIDES; ANIMALS; BONE AND BONES; DEHYDROEPIANDROSTERONE SULFATE; ESTROGENS; FEMALE; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; TIBIA; UTERUS; WEIGHT GAIN;

EID: 0029873398     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900046     Document Type: Article

References (40)

1. Baran D, Bergfeld M, Teitelbaum S, Avioli L (1978) Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male. Calcif Tissue Res 26:103-106
2. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DL, Crawley WF (1987) Osteoporosis in men with idiopathic hypogonadotrophic hypogonadism. Ann Int Med 106:354-361
3. Wakely GK, Schutte HD, Hannon KS, Turner RT (1991) Androgens prevents loss of cancellous bone in the orchidectomized rat. J Bone Miner Res 6:325-329
4. Vanderschueren D, Van Herck E, Suiker AMH, Visser WJ, Schot LPC, Bouillon R (1992) Bone and mineral metabolism in aged male rats: short- and long-term effects of androgen deficiency. Endocrinology 130:2906-2916
5. Deutsch S, Benjamin F, Seltzer V, Tafreshi M, Kocheril G, Frank A (1987) The correlation of serum estrogens and androgens with bone density in late menopause. Int J Gynecol Obstet 25:217-225
6. Devogelaer JP, Crabbe J, Nagant de Deuxchaisnes C (1987) Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass. Br Med J 294:798-800
7. Buchanan J, Myers C, Lloyd T, Leuenberger P, Demers L (1988) Determinants of peak trabecular bone density in women: the role of androgens, estrogens, and exercise. J Clin Endocrinol Metab 3:673-679
8. Buchanan JR, Hospodar P, Myers C, Leuenberger P, Demers LM (1988) The effect of excess endogenous androgens on bone density in young women. J Clin Endocrinol Metab
9. Dixon JE, Rodin A, Murby B, Chapman MG, Fogelman I (1989) Bone mass in hirsute women with androgen excess. Clin Endocrinol 30:271-277
10. Goulding A, Gold E (1993) Flutamide-mediated androgen blockade evokes osteopenia in the female rat. J Bone Miner Res 8:763-769
11. Tobias JH, Gallagher A, Chambers TJ (1994) 5α-dihydrotestosterone partially restores cancellous bone volume in osteopenic ovariectomized rats. Am J Physiol 267:E853-E859
12. Furr BJA, Valcaccia B, Curry B, Woodburn JR, Chesterson G, Tucker H (1987) ICI 176 334: a novel non-steroidal, peripherally selective antiandrogen. J Endocrinol 113:R7-9
13. Furr BJA (1988) Pharmacological properties and potential clinical utility of ICI 176, 334: a novel, non-steroidal, peripherally selective antiandrogen. In: Motta M, Serio M (eds) Hormonal aspects of prostatic disease. Basic and clinical aspects. pp 148-161
14. Freeman SN, Mainwaring WIP, Furr BJA (1989) A possible explanation for the peripheral selectivity of a novel non-steroidal pure antiandrogen. Casodex (ICI 176334). Br J Cancer 60:664-668
15. Furr BJA (1989) Casodex (ICI 176 334) - a new, pure, peripherally selective antiandrogen: preclinical studies. Horm Res 32:69-76
16. Parfitt AM, Matthews CHE, Villeneuve AR, Kleerekoper M (1983) Relationships among surface, volume and thickness of iliac trabecular bone in ageing and in osteoporosis. J Clin Invest 72:1396-1409
17. Albright F (1947) Osteoporosis. Ann Int Med 27:861-882
18. Richelson LS, Heinze HW, Melton LI III, Riggs BL (1984) Relative contributions of ageing and estrogen deficiency to postmenopausal bone loss. N Engl J Med 311:1273-1275
19. Smith EP, Boyd J, Graeme RF, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in man. N Engl J Med 331:1056-1060
20. Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-86
21. Benz DJ, Haussler MR, Thomas MA, Speelman B, Komm BS (1991) High-affinity androgen binding and androgenic regulation of a(1)-procollagen and transforming growth factor-β steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology 128:2723-2730
22. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Kore M, Greene GL, O'Malley BW, Haussler MR (1988) Estrogenic binding, receptor mRNA and biologic response in osteoblast-like osteosarcoma cells. Science 241:81-84
23. Christiansen C, Christiansen MS, Larsen N-E, Transbol I (1982) Pathophysiological mechanism of estrogen effect on bone metabolism: dose-response relationship in early postmenopausal women. J Clin Endocrinol Metab 55:1124-1130
24. Wronski TJ, Cintron M, Doherty AL, Dann LM (1988) Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681-686
25. Wronski TJ, Cintron M, Dann LM (1988) Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 43:179-183
26. Gallagher A, Chambers TJ, Tobias JH (1993) The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats. Endocrinology 133:2787-2791
27. Parfitt AM (1979) Quantum concept of bone remodeling and turnover: implications for the pathogenesis of osteoporosis. Calcif Tissue Int 28:1-5
28. Wronski TJ, Schenck PA, Cintron M, Walsh CC (1987) Effect of body weight on osteopenia in ovariectomized rats. Calcif Tissue Int 40:155-159
29. Turner RT, Vandersteenhoven JJ, Bell NH (1987) The effects of ovariectomy and 17β-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 2:115-122
30. Chow JWM, Lean JM, Chambers TJ (1992) 17β-estradiol stimulates cancellous bone formation in female rats. Endocrinology 130:3025-3032
31. Westerlind KC, Wakely GK, Evans GL, Turner RT (1993) Estrogen does not increase bone formation in growing rats. Endocrinology 133:2924-2934
32. Abe T, Chow JWM, Lean JM, Chambers TJ (1993) Estrogen does not restore bone lost after ovariectomy in the rat. J Bone Miner Res 8:831-838
33. Vanderschueren D, Van Herck E, Suiker AMH, Visser WJ, Schot LPC, Chung K, Lucas RS, Einhorn TA, Bouillon R (1993) Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat. J Bone Miner Res 8:801-809
34. Rossmanith WG, Schenkel B, Benz R (1994) Role of androgens in the regulation of the human menstrual cycle. Gynecol Endocrinol 8:151-159
35. Marugo M, Bemasconi D, Meozzi M, Del-Monte P, Zino V, Prinarolo P, Badaracco B (1994) The use of flutamide in the management of hirsutism. J Endocrinol Invest 17:195-199
36. Durbridge TC, Morris HA, Parsons AM, Parkinson IH, Moore IJ, Porter S, Need AG, Nordin BEC, Vernon-Roberts B (1990) Progressive bone loss in rats after adrenalectomy and oophorectomy. Calcif Tissue Int 47:383-387
37. Turner RT, Lifrak ER, Beckner M, Wakley GK, Hannon KS, Parker LN (1990) Dehydroepiandrosterone reduces cancellous bone osteopenia in ovariectomized rats. Am J Physiol 258:E673-E677
38. Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551-555
39. Marshall DH, Crilly RG, Nordin BEC (1977) Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women. Br Med J 2:1177-1179
40. Pelc B, Marshall DH, Guha P, Khan MY, Nordin BEC (1978) The relation among plasma androstenedione, plasma oestrone and androstenedione to oestrone conversion rates on postmenopausal women with and without fractures. Clin Sci Mol Med 54:125-131